Literature DB >> 29967844

Parkinsonian Syndrome and Toxoplasmic Encephalitis.

Anca-Adriana Arbune1, Manuela Arbune2, Victorita Stefanescu2.   

Abstract

Toxoplasmosis encephalitis in patients with human immunodeficiency virus may progress rapidly with a potentially fatal outcome. Less common neurological symptoms associated with this are Parkinsonism, focal dystonia, rubral tremor and hemichorea-hemiballismus syndrome. A 58 year old woman suddenly lost consciousness and was admitted to the emergency service. Her medical history was unremarkable, except for frequent headaches in the last year, recurrent herpes simplex skin lesions and an episode of urticaria. A computer tomography scan showed supra and infra-tentorial lesions on suggestive of cerebral toxoplasmosis. Both Toxoplasma gondii and HIV tests were positive. In the intensive care unit, antiparasitic and antiretroviral drugs were administered, and she recovered from the coma after six weeks but presented with tetraparesis, diplopia, and depression. The LCD4 count increased from 7 to 128/mm3. The neurological lesions slowly resolved over the next two months, although postural instability, rigidity, bradykinesia and predominantly left side tremor persisted. Mild improvement was achieved after the administration of levodopa. Associated Parkinsonian syndrome in HIV patients is a rare condition, explained by the location of the brain and basal ganglia lesions, and by the observed effect of Toxoplasma gondii which increases dopamine metabolism in neural cells. Early HIV diagnostic and treatment are necessary to prevent neurological disability.

Entities:  

Keywords:  AIDS; dopamine; parkinsonism; toxoplasmosis

Year:  2016        PMID: 29967844      PMCID: PMC5939133          DOI: 10.1515/jccm-2016-0009

Source DB:  PubMed          Journal:  J Crit Care Med (Targu Mures)        ISSN: 2393-1817


  10 in total

1.  The probable relation between Toxoplasma gondii and Parkinson's disease.

Authors:  Ozlem Miman; Ozge Yilmaz Kusbeci; Orhan Cem Aktepe; Zafer Cetinkaya
Journal:  Neurosci Lett       Date:  2010-03-27       Impact factor: 3.046

2.  Parkinsonism and AIDS: a clinical comparative study before and after HAART.

Authors:  Ana Lucia Zuma de Rosso; James Pitágoras de Mattos; Rosalie Branco Correa; Denise Hack Nicaretta; Sérgio Augusto Pereira Novis
Journal:  Arq Neuropsiquiatr       Date:  2009-09       Impact factor: 1.420

Review 3.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

4.  Dystonia in AIDS: report of four cases.

Authors:  Stewart A Factor; Michelle Troche-Panetto; Susan A Weaver
Journal:  Mov Disord       Date:  2003-12       Impact factor: 10.338

Review 5.  HIV-related movement disorders: epidemiology, pathogenesis and management.

Authors:  Francisco Cardoso
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Movement disorders and AIDS: a review.

Authors:  Winona Tse; Maria G Cersosimo; Jean-Michel Gracies; Susan Morgello; C Warren Olanow; William Koller
Journal:  Parkinsonism Relat Disord       Date:  2004-08       Impact factor: 4.891

7.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

Review 8.  Neurodegeneration and ageing in the HAART era.

Authors:  Bruce J Brew; S M Crowe; A Landay; Lucette A Cysique; Gilles Guillemin
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-06       Impact factor: 4.147

9.  The neurotropic parasite Toxoplasma gondii increases dopamine metabolism.

Authors:  Emese Prandovszky; Elizabeth Gaskell; Heather Martin; J P Dubey; Joanne P Webster; Glenn A McConkey
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

10.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort.

Authors:  Konrad Szewczyk-Krolikowski; Paul Tomlinson; Kannan Nithi; Richard Wade-Martins; Kevin Talbot; Yoav Ben-Shlomo; Michele T M Hu
Journal:  Parkinsonism Relat Disord       Date:  2013-10-12       Impact factor: 4.891

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.